Skip to main content
AmigoFish

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

From PsychRounds: The Psychiatry Podcast · · 17 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).

References:

https://pubmed.ncbi.nlm.nih.gov/41626799/

https://www.ncbi.nlm.nih.gov/books/NBK548187/

https://pubmed.ncbi.nlm.nih.gov/41626799/

Back to PsychRounds: The Psychiatry Podcast · Report a problem